Based in Tampa, Florida, Romark is a research-based pharmaceutical company focused on developing innovative treatments for infectious diseases. The company recently inaugurated its first finished products manufacturing facilities in Puerto Rico, transforming itself into a vertically integrated organization. CEO Marc Ayers extols the strengths of Puerto Rico as manufacturing location and explains how the new facility will help Romark meet its global ambitions.
We are developing products for conditions that affect hundreds of millions, perhaps billions of people around the world.
